Overview

Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis

Status:
Not yet recruiting
Trial end date:
2024-09-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety and tolerability of ruxolitinib cream in adolescents with Atopic Dermatitis (AD).
Phase:
Phase 3
Details
Lead Sponsor:
Incyte Corporation